Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAREVAPE varenicline trial for smoking cessation in e-cigarette users
2016-000339-42Phase 4Completed
- Sponsor
- Centro per la Prevenzione e Cura del Tabagismo
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in nicotine dependence comparing Champix with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Nov 2020; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2016-000339-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000339-42.